EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Body Composition and Progression of Biopsy‐Proven Non‐Alcoholic Fatty Liver Disease in Patients With Obesity

Qianyi Wan, Xingzhu Liu, Jinghao Xu, Rui Zhao, Shiqin Yang, Jianrong Feng, Zhan Cao, Jingru Li, Xiaopeng He, Haiou Chen, Jinbao Ye, Haiyang Chen und 1 weitere

Journal of Cachexia, Sarcopenia and Muscle · 2024-12 · 15 (6) · 2608-2617

DOI: 10.1002/jcsm.13605 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, online erschienen am 10.10.2024. Verfasst von Qianyi Wan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Division of Gastrointestinal Surgery, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Body Composition, Obesity, Disease Progression. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Postdoctoral Science Foundation, Postdoctoral Fellowship Program of China Postdoctoral Science Foundation, Sichuan Province Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Obesity is a significant risk factor for the progression of non‐alcoholic fatty liver disease (NAFLD). However, a convenient and efficacious non‐invasive test for monitoring NAFLD progression in patients with obesity is currently lacking. This study aims to investigate the associations between CT‐based body composition and the progression of biopsy‐proven NAFLD in patients with obesity.

Methods

Liver biopsy was conducted in patients with obesity, and the progression of NAFLD was evaluated by the NAFLD activity score (NAS). Body composition was assessed through abdominal computed tomography (CT) scans.

Results

A total of 602 patients with an average age of 31.65 (±9.33) years old were included, comprising 217 male patients and 385 female patients. The wall skeletal muscle index (SMI), total SMI, and visceral fat index (VFI) were positively correlated with NAS in both male and female patients. Multivariate regression analysis demonstrated significant associations between high liver steatosis and wall SMI (HR: 1.60, 95% CI: 1.12 to 2.30), total SMI (HR: 1.50, 95% CI: 1.02 to 2.08), VSI (HR: 2.16, 95% CI: 1.48 to 3.14), visceral fat to muscle ratio (HR: 1.51, 95% CI: 1.05 to 2.18), and visceral to subcutaneous fat ratio (HR: 1.51, 95% CI: 1.07 to 2.12). Non‐alcoholic steatohepatitis (NASH) was significantly associated with wall SMI (HR: 1.52, 95% CI: 1.06 to 2.19) and VSI (HR: 1.50, 95% CI: 1.03 to 2.17). Liver fibrosis ≥ F2 was significantly associated with psoas muscle index (HR: 0.64, 95% CI: 0.44 to 0.93) and psoas skeletal muscle density (HR: 0.61, 95% CI: 0.41 to 0.89).

Conclusions

Our study suggested that certain CT‐based body composition indicators, notably high VFI, were significantly associated with the progression of NAFLD in patients with obesity. Great attentions and timely managements should be given to these patients with body composition characteristics associated with the risk of NAFLD progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseBody CompositionObesityDisease ProgressionHumansMaleFemaleAdultBiopsyTomography, X-Ray ComputedMiddle Aged

Stichwörter der Autor:innen

body compositionnon‐alcoholic fatty liver diseasenon‐alcoholic steatohepatitisobesity

Autor:innen und Institutionen

  • Department of General Surgery, Division of Gastrointestinal Surgery, West China Hospital, Sichuan University, Chengdu, China.
  • West China School of Medicine, Sichuan University, Chengdu, China.
  • Laboratory of Metabolism and Aging Research, National Clinical Research Center for Geriatrics and State key Laboratory of Respiratory Health and Multimorbidity, Frontiers Science Center for Disease-Related Molecular Net…

ORCID-Profile: Yi Chen

Förderung

  • China Postdoctoral Science Foundation
  • Postdoctoral Fellowship Program of China Postdoctoral Science Foundation
  • Sichuan Province Natural Science Foundation
  • National Natural Science Foundation of China
  • Natural Science Foundation of Sichuan Province

Zitieren

APA

Wan, Q., Liu, X., Xu, J., Zhao, R., Yang, S., Feng, J., Cao, Z., Li, J., He, X., Chen, H., Ye, J., Chen, H., & Chen, Y. (2024). Body Composition and Progression of Biopsy‐Proven Non‐Alcoholic Fatty Liver Disease in Patients With Obesity. Journal of Cachexia, Sarcopenia and Muscle, 15(6), 2608-2617. https://doi.org/10.1002/jcsm.13605

Vancouver

Wan Q, Liu X, Xu J, Zhao R, Yang S, Feng J, et al. Body Composition and Progression of Biopsy‐Proven Non‐Alcoholic Fatty Liver Disease in Patients With Obesity. Journal of Cachexia, Sarcopenia and Muscle. 2024;15(6):2608-2617. doi:10.1002/jcsm.13605

BibTeX
@article{Wan2024,
  author = {Wan, Qianyi and Liu, Xingzhu and Xu, Jinghao and Zhao, Rui and Yang, Shiqin and Feng, Jianrong and Cao, Zhan and Li, Jingru and He, Xiaopeng and Chen, Haiou and Ye, Jinbao and Chen, Haiyang and Chen, Yi},
  title = {Body Composition and Progression of Biopsy‐Proven Non‐Alcoholic Fatty Liver Disease in Patients With Obesity},
  journal = {Journal of Cachexia, Sarcopenia and Muscle},
  year = {2024},
  volume = {15},
  number = {6},
  pages = {2608--2617},
  doi = {10.1002/jcsm.13605}
}
Kostenlos starten →